Close Menu
  • Home
  • Understanding Dementia
  • Caregiver Resources
  • Helpful Products
  • News
What's Hot

Blood test shows high accuracy in detecting Alzheimer’s disease

Better brain care score linked to lower risk of heart disease and cancer

Pennington Biomedical’s Greaux Healthy initiative launches to improve child health in Louisiana

Facebook X (Twitter) Instagram
  • Home
  • Understanding Dementia
  • Caregiver Resources
  • Helpful Products
  • News
Facebook X (Twitter) Instagram Pinterest
DEMENTIA PLANETDEMENTIA PLANET
Subscribe Now
  • About Us
  • Contact
  • Privacy Policy
  • Terms & Conditions
DEMENTIA PLANETDEMENTIA PLANET
You are at:Home»News»Research uncovers new mechanism in protein aggregation linked to Parkinson’s disease
News

Research uncovers new mechanism in protein aggregation linked to Parkinson’s disease

002 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

A team of researchers from Kumamoto University has discovered a groundbreaking mechanism in the formation of harmful protein aggregates that lead to neurodegenerative diseases such as Parkinson’s disease. The team, led by Professor Norifumi Shioda and Associate Professor Yasushi Yabuki, has identified for the first time that unique RNA structures called G-quadruplexes (G4s) play a central role in promoting the aggregation of α-synuclein, a protein that is associated with neurodegeneration. By demonstrating that inhibiting G4 assembly could potentially prevent the onset of synucleinopathies, this discovery positions G4 as a promising target for early intervention in these diseases.

In a healthy state, α-synuclein typically regulates neuronal function. However, in neurodegenerative diseases it accumulates, leading to cell damage and motor symptoms. The researchers identified that G4s, four-stranded RNA structures that form in response to cellular stress, function as a “scaffold” that facilitates the aggregation of α-synuclein. Elevated calcium levels, often seen under stress, trigger G4 assembly, which then recruits α-synuclein, converting it to a damaging, aggregate-prone state.

The team went one step further and demonstrated a new approach to prevent this process. They administered 5-aminolevulinic acid (5-ALA), a compound that blocks G4 formation, to model mice exhibiting Parkinson’s-like symptoms. Impressively, 5-ALA treatment not only prevented α-synuclein aggregation but also halted the progression of motor symptoms, a promising sign for potential therapies targeting early-stage neurodegeneration.

This breakthrough could significantly advance treatments targeting neurodegenerative diseases by focusing on G4 regulation. Because G4s are also involved in other diseases such as Alzheimer’s disease, this discovery could expand the impact of such treatments beyond Parkinson’s disease. These findings were published in the journal Cell on October 18, 2024, shedding new light on preventive strategies to combat neurodegeneration and improve the quality of life in the aging population.

See also  Education, wealth, and job type shape aging brains and cognitive health

Source:

Magazine reference:

Matsuo, K., et al. (2024). RNA G-quadruplexes form scaffolds that promote neuropathological α-synuclein aggregation. Cell. doi.org/10.1016/j.cell.2024.09.037.

aggregation Disease linked mechanism Parkinsons protein Research uncovers
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleGlaucoma medication may help prevent Alzheimer’s-related tau build-up
Next Article Study links brain proteins to individual differences in functional connectivity

Related Posts

Blood test shows high accuracy in detecting Alzheimer’s disease

Better brain care score linked to lower risk of heart disease and cancer

Pennington Biomedical’s Greaux Healthy initiative launches to improve child health in Louisiana

Add A Comment
Leave A Reply Cancel Reply

Ads

Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss

Exercise linked to lower mortality risk in dementia patients

Physical activity of any intensity after a dementia diagnosis is associated with an approximately 30%…

Sleep too much or too little? Your cognition pays the price

The Key Role of iPSC-Derived Microglia in Research and Drug Discovery

Study links protein increases to cognitive improvement in Alzheimer’s

About Us
About Us

Our blog offers essential insights, tips, and support for those caring for loved ones with Dementia. Discover practical advice, research updates, and community stories.

We're accepting new partnerships right now.

Facebook X (Twitter) Instagram YouTube
© 2025 dementiaplanet.com - All rights reserved.
  • About Us
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.